Aker BioMarine ASA (OSL:AKBM)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other/Eliminations	-16.70M	-18.10M	-20.70M	-14.30M	-17.90M
Human Health Ingredients	118.20M	97.90M	83.70M	-	-
Consumer Health Products	108.50M	109.40M	122.20M	-	-
Emerging Businesses	8.30M	9.70M	11.10M	-	-
Ingredients	-	-	-	176.60M	169.60M
Brands	-	-	-	114.90M	110.40M
Total	218.30M	198.90M	196.30M	277.20M	262.10M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
EMEA	31.10M	21.00M	15.40M	50.90M	54.00M
Americas	146.90M	140.80M	145.70M	144.30M	138.60M
Asia Pacific	40.10M	37.20M	35.00M	55.20M	46.60M
Norway	-	-	200.00K	26.80M	22.90M
Total	218.10M	199.00M	196.30M	277.20M	262.10M

Data Source: S&P Global Market Intelligence Last updated: Jul 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 1, 2026

Data Sources Report a data error